Global Genomics Personalized Health Market Insights, Forecast to 2028

Genomics Personalized Health Market 

The global Genomics Personalized Health market size is projected to reach USD 16780 Million by 2028, from USD 9232.4 Million in 2021, at a CAGR of 8.4% during 2022-2028.

The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.

Fully considering the economic change by this health crisis, NGS Platforms accounting for % of the Genomics Personalized Health global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Academics & Research Institutes segment is altered to an % CAGR throughout this forecast period.

China Genomics Personalized Health market size is valued at US$ million in 2021, while the North America and Europe Genomics Personalized Health are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Genomics Personalized Health landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomics Personalized Health market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomics Personalized Health market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomics Personalized Health market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomics Personalized Health market.

Genomics Personalized Health market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Genomics Personalized Health market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

• NGS Platforms
• RT-PCR
• Microarray
• Genetic Analyzers

By Application

• Academics & Research Institutes
• Diagnostic Centers

By Company

• QIAGEN
• Illumina
• Thermo Fisher Scientific
• Bio-Rad
• Roche
• Lonza
• INVITAE
• Genetic Technologies
• Interleukin Genetics
• Eastern Biotech
• DNA Genotek
• UBiome
• XCode Life

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA